This research aimed to develop the population-based preference scores of the EQ-5D-5L (the 5L), Thai version in an effort to compare the measurement properties of the 5L with those of the EQ-5D-3L (the 3L), and to compare the results of an economic evaluation from a 2014 study that used the 5L compared with the 3L. To elicit population-based prefer

Reference: Tarn YH, Hu S, Kamae I, Yang BM, Li SC, Tangcharoensathien V, Teerawattananon Y, Limwattananon S, Hameed A, Aljunid SM, Bapna JS. Health-care systems and pharmacoeconomic research in Asia-Pacific region. Value Health. 2008;11(Suppl 1):S137-55. Link: http://www.ncbi.nlm.nih.gov/pubme

Health technology assessments as a mechanism for increased value for money: recommendations to the Global Fund. Yot Teerawattananon1*, Kate McQueston2, Amanda Glassman2, Jomkwan Yothasamut1,2 and Chaw Yin Myint1,2 Abstract The Global Fund is experiencing increased pressure to optimize resul

Kalipso Chakidou1*, Ryan Li1, Anthony J. Culyer2, Amanda Glassman3, Karen J. Hofman4, Yot Teerawattananon5 1Institute of Global Health Innovation, Imperial College London, London, UK 2Department of Economics & Related Studies and Centre for Health Economics, University of York, York, UK 3Ce

Abstract Cost-effectiveness analysis (CEA) can help countries attain and sustain universal health coverage (UHC), as long as it is context-specific and considered within deliberative processes at the country level. Institutionalising robust deliberative processes requires significant time and res

Sildenafil is a treatment option for PAH patients that is found to offer an additional 1-3 life years gained for PAH patients compared to beraprost, currently the only treatment available in the benefit package under the National Social Health Insurance (Jaminan Kasehatan Nasional – JKN) of Indonesi

Due to the increasing burden of non-communicable diseases (NCDs) in aging populations and the prevalence of unhealthy lifestyles, end-stage renal disease (ESRD) that results from NCDs is a growing concern in Indonesia. With the target of achieving Universal Health Coverage (UHC) by 2019, public prov

Since 2013, HITAP has supported HTA development and capacity building in the Philippines. In 2019, the Philippines mandated the provision of universal health coverage to all Filipinos. To support the decision-making for this promising undertaking, the partners continue their collaboration through technical assisatance on national HTA guidelines, on